Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

VHZ reported for 2023 by RAS

4/2/24 VLHZ

Moscow Exchange summarized the results of trading in March

4/2/24 MOEX

Kamaz reported for 2023 by IFRS

4/2/24 KMAZ

Astra may acquire two cloud service providers

4/2/24 ASTR

SGC reported for 2023 by RAS

4/2/24 UGLD

Zaimer plans to open a collection agency

4/2/24 ZAYM

General Director of PIK became Yervand Karapetyan

4/2/24 PIKK

Samaraenergo reported for 2023 by RAS

4/2/24 SAGO

Fesco reports for 2023 by RAS

4/2/24 FESH

Pyatyorochka has entered Yakutia

4/2/24 X5